Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3014 Target Snapshot

Proto-oncogene tyrosine-protein kinase Src · SINGLE PROTEIN · Rattus norvegicus

52Compounds
13Assays
0Approved Drugs
44.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9WUD9. Use UniProt Q9WUD9 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9WUD9 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Proto-oncogene tyrosine-protein kinase Src as ChEMBL target CHEMBL3014, mapped to UniProt Q9WUD9. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Proto-oncogene tyrosine-protein kinase Src
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3014
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9WUD9
Proto-oncogene tyrosine-protein kinase Src
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Proto-oncogene tyrosine-protein kinase Src is the right protein anchor across sources, using UniProt Q9WUD9 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProto-oncogene tyrosine-protein kinase Src
UniProt AccessionQ9WUD9
Component TypeProtein
Sequence Length536 aa

Proto-oncogene tyrosine-protein kinase Src

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Proto-oncogene tyrosine-protein kinase Src, mapped to UniProt Q9WUD9. Sequence length is 536 aa.

Mapped IDQ9WUD9
Review nameProto-oncogene tyrosine-protein kinase Src
OrganismRattus norvegicus
Assay Mix

Activity Type Distribution

IC5044.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL315575 7.89 IC50 13.0 Preclinical
CHEMBL313587 7.85 IC50 14.0 Preclinical
CHEMBL85730 7.77 IC50 17.0 Preclinical
CHEMBL83069 7.6 IC50 25.0 Preclinical
CHEMBL311607 7.37 IC50 43.0 Preclinical
CHEMBL83305 7.27 IC50 54.0 Preclinical
CHEMBL85011 7.25 IC50 56.0 Preclinical
CHEMBL83070 7.17 IC50 67.0 Preclinical
CHEMBL314705 7.16 IC50 70.0 Preclinical
CHEMBL391738 7.14 IC50 73.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
4
5.5
7
6.0
6
6.5
6
7.0
4
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

13
Total Assays
24
Tested Compounds
2
Assay Types
Binding — 10 assays, 24 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 8 11 6.3
cell-based format 2 13 7.1
Functional — 3 assays, 8 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 1 7.9
assay format 1 7 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine